Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Altea Research
mi
from
Las Vegas, NV
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Altea Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pahl Pharmaceutical Professionals, LLC
mi
from
Oklahoma City, OK
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pahl Pharmaceutical Professionals, LLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
SP Research, PLLC
mi
from
Oklahoma City, OK
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
SP Research, PLLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
CODA, Inc.
mi
from
Portland, OR
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
CODA, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Keystone Clinical Solutions, Inc.
mi
from
Altoona, PA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Keystone Clinical Solutions, Inc.
mi
from
Altoona, PA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Rakesh Ranjan, MD & Associates Inc.
mi
from
Garfield Heights, OH
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Rakesh Ranjan, MD & Associates Inc.
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol
Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol
Status: Enrolling
Updated:  12/31/1969
Guthrie Clinic, Ltd.
mi
from
Sayre, PA
Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol
Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol
Status: Enrolling
Updated: 12/31/1969
Guthrie Clinic, Ltd.
mi
from
Sayre, PA
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
Arizona Reginal Medical Research
mi
from
Tucson, AZ
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Arizona Reginal Medical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
Advanced Foot Care and Clinical Research Center
mi
from
Fresno, CA
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Advanced Foot Care and Clinical Research Center
mi
from
Fresno, CA
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
SAVAHCS
mi
from
Tucson, AZ
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
SAVAHCS
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
Richard C. Galperin, DPM
mi
from
Dallas, TX
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Richard C. Galperin, DPM
mi
from
Dallas, TX
Click here to add this to my saved trials
Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
Mesenteric Sparing Versus High Ligation Ileocolic Resection for the Prevention of Recurrent Crohn's Disease
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
Mesenteric Sparing Versus High Ligation Ileocolic Resection for the Prevention of Recurrent Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Status: Enrolling
Updated:  12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Status: Enrolling
Updated: 12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated:  12/31/1969
University of Louisville School of Medicine
mi
from
Louisville, KY
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated: 12/31/1969
University of Louisville School of Medicine
mi
from
Louisville, KY
Click here to add this to my saved trials
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated:  12/31/1969
Our Lady of the Lake Regional Medical Center
mi
from
Baton Rouge, LA
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated: 12/31/1969
Our Lady of the Lake Regional Medical Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated:  12/31/1969
St Josef's Hospital
mi
from
Wiesbaden,
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated: 12/31/1969
St Josef's Hospital
mi
from
Wiesbaden,
Click here to add this to my saved trials
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated:  12/31/1969
University Surgical Associates
mi
from
Providence, RI
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A Retrospective Review of the Use of the Cook Biodesign® Fistula Plug (C-FPS-0.2, C-FPS-0.4, and C-FPS-0.7) to Treat Anorectal Fistulas
Status: Enrolling
Updated: 12/31/1969
University Surgical Associates
mi
from
Providence, RI
Click here to add this to my saved trials
ACELL Mesh for Paraesophageal Hernia Repair
Comparison of Symptomatic and Radiographic Outcomes of Paraesophageal Hernia Repair With and Without MatriStem Surgical Matrix
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
ACELL Mesh for Paraesophageal Hernia Repair
Comparison of Symptomatic and Radiographic Outcomes of Paraesophageal Hernia Repair With and Without MatriStem Surgical Matrix
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Treating Anorectal Dysfunction in MS
Treating Anorectal Dysfunction Associated With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Treating Anorectal Dysfunction in MS
Treating Anorectal Dysfunction Associated With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
Full-replicate Study of APRISO 375 mg Extended-release Capsules Versus the Approved APRISO 375 mg Extended-release Capsules in Healthy Male and Female Subjects
Status: Enrolling
Updated:  12/31/1969
Valeant Site 11
mi
from
San Diego, CA
Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects
Full-replicate Study of APRISO 375 mg Extended-release Capsules Versus the Approved APRISO 375 mg Extended-release Capsules in Healthy Male and Female Subjects
Status: Enrolling
Updated: 12/31/1969
Valeant Site 11
mi
from
San Diego, CA
Click here to add this to my saved trials
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis
Status: Enrolling
Updated:  12/31/1969
Wesy haven va
mi
from
West Haven, CT
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Wesy haven va
mi
from
West Haven, CT
Click here to add this to my saved trials
Delayed Cord Clamping for Congenital Diaphragmatic Hernia
Delayed Cord Clamping for Intubation and Gentle Ventilation in Infants With Congenital Diaphragmatic Hernia
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Delayed Cord Clamping for Congenital Diaphragmatic Hernia
Delayed Cord Clamping for Intubation and Gentle Ventilation in Infants With Congenital Diaphragmatic Hernia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Impact of Diet on Functional Gastrointestinal Symptoms
Impact of Diet on Functional Gastrointestinal Symptoms; a National Population Based Survey
Status: Enrolling
Updated:  12/31/1969
Cincinnati Urogynecology Associates
mi
from
Cincinnati, OH
Impact of Diet on Functional Gastrointestinal Symptoms
Impact of Diet on Functional Gastrointestinal Symptoms; a National Population Based Survey
Status: Enrolling
Updated: 12/31/1969
Cincinnati Urogynecology Associates
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
Pilot Pharmacokinetic Study of Dose Adjustment of Vinorelbine in Patients With Varying Degree of Liver Dysfunction
Status: Enrolling
Updated:  12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
Pilot Pharmacokinetic Study of Dose Adjustment of Vinorelbine in Patients With Varying Degree of Liver Dysfunction
Status: Enrolling
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
Pilot Pharmacokinetic Study of Dose Adjustment of Vinorelbine in Patients With Varying Degree of Liver Dysfunction
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
Pilot Pharmacokinetic Study of Dose Adjustment of Vinorelbine in Patients With Varying Degree of Liver Dysfunction
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding
A Comparison of Early Deployment of a Video Capsule (Endocapsule EC-10: Olympus Tokyo. Japan) in the Emergency Department Versus Standard of Care Workup of Non-hematemesis Gastrointestinal Bleeding
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts Memorial Medical Center - University Campus
mi
from
Worcester, MA
Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding
A Comparison of Early Deployment of a Video Capsule (Endocapsule EC-10: Olympus Tokyo. Japan) in the Emergency Department Versus Standard of Care Workup of Non-hematemesis Gastrointestinal Bleeding
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center - University Campus
mi
from
Worcester, MA
Click here to add this to my saved trials
Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems
Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems
Status: Enrolling
Updated:  12/31/1969
Sala Institute for Child and Family Centered Care
mi
from
New York, NY
Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems
Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems
Status: Enrolling
Updated: 12/31/1969
Sala Institute for Child and Family Centered Care
mi
from
New York, NY
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
New York, NY
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
New York, NY
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Miami, FL
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Boston, MA
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Boston, MA
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Philadelphia, PA
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Galveston, TX
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Galveston, TX
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Salt Lake City, UT
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Seattle, WA
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Seattle, WA
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Parkville,
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Parkville,
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Little Rock, AR
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Ann Arbor, MI
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
San Francisco, CA
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Ipatasertib in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Ipatasertib in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Ipatasertib in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Ipatasertib in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials